Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Use camera
Select from library
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Goodbye! and best wishes in your recovery
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Product: Artichoke

Updated: May 12, 2020 9:35 PM

May 12, 2020 9:35 PM

“The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced the recall of approximately 3,302 pounds of meat and poultry flatbread ... See More/product/pizza#scroll" title="Product: Pizza">pizza products by Ideal Foods that were produced, packed, and distributed without the benefit of federal inspection. There have been no confirmed reports of adverse reactions related to this recall to date.

The recalled products were produced on various dates from October 2019 to April 2020 and bear establishment number “EST. 45351A” or “P-45351A” inside the USDA mark of inspection. These items were shipped to a distributor and retail locations in California.

- 13.5-oz. plastic-wrapped cardboard trays containing “culinevo Artisan Style Flatbread Pizza CARNE ASADA”.
- 13-oz. plastic-wrapped cardboard trays containing “culinevo Artisan Style Flatbread Pizza CHICKEN SPINACH ARTICHOKE”.
- 16.5-oz. plastic-wrapped cardboard trays containing “culinevo Artisan Style Flatbread Pizza SIZZLIN JALAPEÑO”.
- 14.5-oz. plastic-wrapped cardboard trays containing “culinevo Artisan Style Flatbread Pizza MEAT LOVERS”.

FSIS advises consumers who have purchased these products not to consume them. These products should be thrown away or returned to the place of purchase.

Check the full recall details on the FSIS website fsis.usda.gov

Source: FSIS See Less
Reported By SafelyHQ.com User

Recent Interesting Reports

July 7, 2020 3:00 PM

“Company name: Mylan Institutional LLC
Brand name: Mylan
Product recalled: Daptomycin for Injection
Reason of the recall: Presence of particulate matter
FDA Recall date: July 07, 2020
Recall details: Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is ... See Moreconducting a voluntary nationwide recall to the consumer level of one lot of Daptomycin for Injection, 500 mg/vial due to the presence of particulate matter found in one single-dose vial manufactured by Mylan Laboratories Limited’s Specialty Formulation Facility. To date, Mylan has not received any reports of adverse events related to this recall.

Intravenous administration of a solution containing visible particulates could lead to serious adverse events including, but not limited to, local irritation, vasculitis/phlebitis, antigenic or allergic reactions, and microvascular obstruction, including pulmonary embolism. This batch was distributed nationwide to wholesalers and retail pharmacies between April 2020 and May 2020. The recalled batch is as follows:

- NDC #: 67457-813-50
- Material Description: Daptomycin for Injection
- Strength: 500 mg/vial
- Size: 20 mL vial
- Lot No: 7605112
- Expiry: October 2021

Daptomycin for injection is an injectable antibacterial indicated for the treatment of complicated skin and skin structure infections (cSSSI) and staphylococcus aureus bloodstream infections (bacteremia) in adult patients.

Mylan is notifying its distributors and customers by letter and is arranging for return of all recalled products. Consumers/distributors/retailers that have product which is being recalled should stop use/further distribution or dispensing.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

Coop Tuna Chunks, Co-op Food - Brookfield, The Old Community Centre, Brookfield Ct, Ashford TN23 5ER, United Kingdom

Symptoms: Other
Co-op Food - Brookfield, The Old Community Centre, Brookfield Ct, Ashford TN23 5ER, United Kingdom

June 5, 2020 4:09 AM

“I had tinned tuna around 8:15pm on 4th June. I noticed the tuna appeared strange after a few normal mouthfuls. T ... See Morehe next mouthful I had my mouth was immediately stinging and it tasted slightly metallic. This put me off and I stopped eating, however, my dog had also had a small amount in her dinner. Quite soon after my stomach felt unsettled. About 30 minutes later I had heart palpitations which lasted a short while. About an hour after eating I had itchy hive like bumps appear on my stomach and lower back. My stomach and chest appeared flushed and hot. The hive bumps persisted for a few hours but I had no further symptoms. My dogs stomach also appeared unsettled soon after she ate, as her peristalsis was audible. About 3 hours after she ate the tuna she was sick and appeared quite lethargic. About 6 hours later she felt very hot to the touch and was scratching. 12 hours later she was back to normal. See Less
Reported By SafelyHQ.com User

May 28, 2020 5:32 PM

“Company name: Apotex Corp
Brand name: Apotex Corp
Product recalled: Metformin Hydrochloride Extended-Release Tablets, USP 500mg
Reason of the recall: Due to detection of N-Nitrosodimethylamine (NDMA)
FDA Recall date: May 28, 2020
Recall details: Apotex Corp is voluntarily recalling all lots ... See Moreof Metformin Hydrochloride Extended-Release Tablets, USP 500mg within expiry to retail level. Apotex was notified by the U.S. Food and Drug Administration (US FDA) that one lot of Metformin Hydrochloride Extended-Release Tablets, USP was tested and showed results for N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit (ADI) and recommended recall of the one tested lot. Apotex Corp has agreed to recall this lot, and out of an abundance of caution, the company is extending the recall to all lots of Metformin Hydrochloride Extended-Release Tablets in the US.

Apotex stopped selling this product in the US in February 2019, and there remains only limited product on the market. To date, Apotex has not received any reports of adverse events related to use of the product. Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables. Metformin Hydrochloride Extended-Release Tablets, USP is a prescription oral product indicated as an adjunct to diet and exercise to improve blood sugar control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. The affected Metformin Hydrochloride Extended-Release Tablets, USP can be identified by NDC numbers stated on the product label.

- Product: Metformin Hydrochloride Extended-Release Tablets, USP
- Strength: 500mg
- Pack Size: 100's Bottle
- NDC Number: 60505-0260-1

The affected Metformin Hydrochloride Extended-Release Tablets were distributed nationwide in the USA to Warehousing Chains.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

March 25, 2020 12:41 PM

“The company’s Soho location closed earlier this week. The employee who tested positive for COVID-19 was last in the Soho store on Tuesday, March 17, according to a company spokesperson. It’s still up-in-the-air when the Soho Trader Joe’s will reopen, but standard protocol is to close at least three ... See Moredays for cleaning.

“Out of an abundance of caution, we have temporarily closed the store for thorough cleaning and sanitization. As soon as the store has been fully cleaned and restocked, we plan to reopen,” Trader Joe’s said in an announcement on their website.
Source: ny.eater.com
See Less
Reported By SafelyHQ.com User

June 18, 2020 11:00 PM

“Company name: GSK Consumer Healthcare
Brand name: Robitussin
Product recalled: Cough and cold products
Reason of the recall: Incorrect dosing cups
FDA Recall date: June 18, 2020
Recall details: GSK Consumer Healthcare is voluntarily recalling to the retail level two lots (listed below) of Ch ... See Moreildren's Robitussin® Honey Cough and Chest Congestion DM and one lot of Children's Dimetapp® Cold and Cough, due to the inclusion of incorrect dosing cups. During the review of the packaging documents for these products, GSK discovered that the dosing cups for the Children's Robitussin® Honey product are missing the 5 mL and 10 mL graduations, while the dosing cups for the Children's Dimetapp® product are missing the 10 mL graduation. The dosing cups packaged with both products only have the 20 mL graduation.

There is a potential risk of accidental overdose if caregivers dispensing the syrup do not notice the discrepancies between the graduations printed on the dosing cups and the indicated amounts to be administered (as directed in the instructions for use). Children's Robitussin Honey Cough & Chest Congestion DM contains 10 mg dextromethorphan HBr USP and guaifenesin USP 100 mg per 10 mL, and is labeled for children 4 and older, as well as adults. Children's Dimetapp Cold & Cough contains 2 mg brompheniramine maleate USP, 10 mg dextromethorphan HBr USP, and 5 mg phenylephrine HCl USP per 10 mL, and is labeled for children 6 and older, as well as adults.

Symptoms of overdose of either product may include any of the following: impaired coordination; brain stimulation causing increase in energy, elevation in blood pressure, heart rate, and respiration; a lack of energy and enthusiasm; severe dizziness or drowsiness; slow heart rate; fainting; psychotic behaviour; restlessness; seizure; decreased respiration; nausea; vomiting; constipation; diarrhea; abdominal pain; visual and hearing hallucinations; urinary retention.

As of the date of the recall announcement, GSK Consumer Healthcare has not received any adverse events related to these products or consumer complaints regarding the incorrect dosing cups supplied with the product. The recall is limited to the three lots listed below:

Children's Robitussin® Honey Cough and Chest Congestion DM (4oz)
NDC 0031-8760-12
Lots: 02177 (Exp. Jan. 2022) / 02178 (Exp. Jan. 2022)

Children's Dimetapp® Cold and Cough (8oz)
NDC 0031-2234-19
Lot: CL8292 (Exp. Sep. 2021)

These lots were distributed nationwide between February 5, 2020 and June 3, 2020 within the United States. GSK Consumer Healthcare has notified wholesalers, distributors and retailers to arrange for return of any recalled product. Wholesalers, distributors and retailers with an existing inventory of the lots being recalled should stop distribution and quarantine these lots immediately.

Wholesalers, distributors and retailers that have further distributed the recalled product should notify any accounts or additional locations which may have received the recalled product from them. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. In December 2018, GlaxoSmithKline plc reached an agreement with Pfizer, Inc. to combine their consumer health businesses into a new Joint Venture. August 01, 2019 was the first day of the new GSK Consumer Healthcare Joint Venture. Thus, when identifying impacted product, please be aware the Pfizer company name will still be present on the label.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

April 12, 2020 12:00 PM

“Details: On Friday, Jacksonville University (JU) confirmed that an Aramark employee working at Riverview Cafe on campus has tested positive for COVID-19.
The university says the individual last worked in the cafe on April 4th. The cafe will be closed to allow time for cleaning and sanitization. ... See MoreReport: 4/10/2020
Source: firstcoastnews.com
See Less
Reported By SafelyHQ.com User

June 10, 2020 7:52 PM

“Peaceful Black Lives Matter protest through brooklyn on bikes See Less
Reported By SafelyHQ.com User

April 12, 2020 12:00 PM

“Details: A sixth employee at a ShopRite in the Hudson Valley has tested positive for the novel coronavirus (COVID-19).
The store is asking colleagues who may have been in close contact with that person to self-quarantine for a period of 14 days

Report: 4/10/2020
Source: dailyvoice.com See Less
Reported By SafelyHQ.com User

May 22, 2020 4:00 PM

“Company name: Acella Pharmaceuticals, LLC
Brand name: Acella
Product recalled: 30-mg, 60-mg and 90-mg NP Thyroid®
Reason of the recall: Super potency
FDA Recall date: May 22, 2020
Recall details: Company Announcement Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30 ... See More-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. The products are being recalled because our testing has found these lots to be superpotent. The product may have up to 115.0% of the labeled amount of Liothyronine (T3). Risk Statement: Patients being treated for hypothyroidism (underactive thyroid), who receive superpotent NP Thyroid, may experience signs and symptoms of hyperthyroidism (overactive thyroid) which include, but are not limited to, weight loss, heat intolerance, fatigue, muscle weakness, hypertension, chest pain, rapid heart rate, or heart rhythm disturbances. Pregnant women who take superpotent NP Thyroid may also experience negative maternal and fetal outcomes including miscarriage and/or impairment to fetal development. Patients should talk to their healthcare professional before they stop taking their NP Thyroid medicine. To date, Acella has received two reports of adverse events known to be related to this recall. NP Thyroid (thyroid tablets, USP) is composed of levothyroxine and liothyronine, and used to treat hypothyroidism (underactive thyroid). The products subject to recall are packed in 100-count bottles. See product images. To best identify the product, the NDC’s, Product Description, Lot Numbers and Expiration Dates are listed. These lots were distributed nationwide in the USA to Acella’s direct accounts.
Check the full recall details on fda.gov
Source: FDA
See Less
Reported By SafelyHQ.com User

May 27, 2020 9:34 AM

“I contacted the manager at your store because my sister consumed an undercooked burger last night and is now very sick. He said that there was no way she can get sick from ... See Mores://safelyhq.com/product/beef#scroll" title="Product: Beef">beef even though a quick google search says otherwise. I’m very disappointed. See Less
Reported By SafelyHQ.com User